Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Relationship of connective tissue dysplasia and hypomagnesemia in genesis of juvenile dysmenorrhea therapy

Oltinoy Yakubova

. 2012 ; 2012 (3) : 5-6.

Jazyk angličtina Země Česko Médium elektronický zdroj

Perzistentní odkaz   https://www.medvik.cz/link/bmc14045969

We studied the relationship of connective tissue state with magnesium and hydroxyproline levels in blood and urine of young women with primary dysmenorrhea. Study showed that in girls with dysmenorrhea and phenomena of connective tissue dysplasia hydroxyproline level in urine was increased which was associated with increased degradation of collagen and decreased level of magnesium in blood serum. This should be noted in differentiated approach to the treatment of dysmenorrhea.

Relationship of connective tissue dysplasia and hypomagnesemia in genesis of juvenile dysmenorrhea therapy [elektronický zdroj] /

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14045969
003      
CZ-PrNML
005      
20141031112643.0
007      
cr|cn|
008      
140214s2012 xr fs 000 0eng||
009      
eAR
024    7_
$a 10.12955/emhpj.v3i0.354 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Yakubova, Oltinoy $u Andijan Medical State Institute, Uzbekistan
245    10
$a Relationship of connective tissue dysplasia and hypomagnesemia in genesis of juvenile dysmenorrhea therapy $h [elektronický zdroj] / $c Oltinoy Yakubova
504    __
$a Literatura
520    9_
$a We studied the relationship of connective tissue state with magnesium and hydroxyproline levels in blood and urine of young women with primary dysmenorrhea. Study showed that in girls with dysmenorrhea and phenomena of connective tissue dysplasia hydroxyproline level in urine was increased which was associated with increased degradation of collagen and decreased level of magnesium in blood serum. This should be noted in differentiated approach to the treatment of dysmenorrhea.
650    _2
$a moč $7 D014556
650    _2
$a biochemická analýza krve $7 D001774
650    12
$a hořčík $x fyziologie $7 D008274
650    12
$a hydroxyprolin $x fyziologie $7 D006909
650    _2
$a nemoci pojiva $7 D003240
650    _2
$a bolest $x etiologie $7 D010146
650    _2
$a mladiství $7 D000293
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a dysmenorea $x etiologie $7 D004412
773    0_
$t European medical, health and pharmaceutical journal $x 1804-5804 $g Roč. 2012, č. 3 (2012), s. 5-6 $w MED00177703
856    41
$u https://ojs.journals.cz/index.php/EMHPJ/issue/view/44 $y plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140213090030 $b ABA008
991    __
$a 20141031112648 $b ABA008
999    __
$a ok $b bmc $g 1012963 $s 844503
BAS    __
$a 3 $a 4
BMC    __
$a 2012 $b 2012 $c 3 $d 5-6 $i 1804-5804 $m European Medical, Health and Pharmaceutical Journal $n Eur. Med. Health Pharm. J. $x MED00177703
LZP    __
$c NLK183 $d 20140320 $a NLK 2014-12/vt

Najít záznam

Citační ukazatele

Možnosti archivace